GlassScriptPhysician profile
Alexis A Jimenez
NPI 1942441746
$17,754.78
in general payments reported to CMS, 2019-2025
59 companies · $2,143 in 2025
The $2,143 reported for 2025 was more than what 80% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,716 · 2020: $1,415 · 2021: $3,090 · 2022: $3,754 · 2023: $2,447 · 2024: $2,190 · 2025: $2,143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,709 · Education: $69.77.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,709.24 |
| Education | $69.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $6,570.34 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Superion Indirect Decompression System |
| Medtronic, INC. | $1,771.11 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Nevro Corp. | $844.76 | 2019-2024 | Senza |
| Stimwave Technologies Incorporated | $624.34 | 2019-2022 | |
| Relievant Medsystems, INC. | $543.74 | 2022-2023 | Intracept |
| Medtronic USA, INC. | $495.74 | 2019-2020 | |
| Spr Therapeutics, INC | $478.31 | 2019-2025 | Sprint Pns System |
| Avanos Medical | $441.36 | 2019-2022 | |
| Abbott Laboratories | $439.52 | 2020-2025 | Proclaim, Eterna |
| Amgen INC. | $411.62 | 2019-2022 | |
| Zyla Life Sciences, INC. | $365.72 | 2019-2020 | |
| Flowonix Medical Incorporated | $340.21 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $311.91 | 2025 | |
| Abbvie INC. | $309.47 | 2021-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $308.23 | 2019-2025 | Relistor |
Show all 59 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexis Jimenez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.